Cordyceps Sunshine Biotech Holdings RAJAF Income Statement (2020-2025)

OTC RAJAF

$9.18 +0.00 (+0.00%)

At close: Aug 18, 2026 · 4:00 PM EDT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2020	Dec2021	Dec2022	Sep2023	Dec2023	Dec2024	Dec2025
Revenue & cost
Revenue (Quarter)					0.32M
Cost of Revenue (Quarter)					0.03M
Gross Profit (Quarter)		-0.18M	-0.11M		0.82M
Operating items
Selling, General & Administrative (Quarter)			0.08M		0.35M
Restructuring Costs (Quarter)			0.08M		0.35M
Other Operating Expenses (Quarter)			-0.09M		-0.54M
Operating Expenses (Quarter)			0.08M		0.16M
Operating Income (Quarter)		-0.18M	-0.04M		0.12M
EBIT (Quarter)		-0.18M	-0.04M		0.12M
Non-operating items
Other Non Operating Income (Quarter)			-0.03M		-0.02M
Non Operating Income (Quarter)		-0.01M	-0.08M		-0.04M
Net income details
EBT (Quarter)		-0.18M	-0.04M		0.08M
Profit After Tax (Quarter)		-0.18M	-0.08M		0.67M
Income from Continuing Operations (Quarter)		-0.18M	-0.04M		0.08M
Consolidated Net Income (Quarter)		-0.37M	-0.30M
Income towards Parent Company (Quarter)		-0.37M	-0.30M
Net Income towards Common Stockholders (Quarter)		-0.37M	-0.30M
Additional items
EPS (Basic) (Quarter)		0.00	0.00
EPS (Diluted) (Quarter)		0.00	0.00
Shares Outstanding (Quarter)	100.00M	100.00M	104.42M	111.12M	111.12M	111.12M	111.12M
Shares Outstanding (Diluted) (Quarter)	100.00M	100.00M	104.42M	111.12M	111.12M	111.12M	111.12M
Shares Outstanding (Entity) (Quarter)	100.00M	100.00M	111.12M	111.12M	111.12M	111.12M	111.12M
EBITDA (Quarter)		-0.18M	-0.04M		0.12M
Interest Expenses (Quarter)			0.06M	0.03M	0.08M	0.01M	0.01M